“… Country | Positive/examined (%) | Genotypes a ( n ) | Ref. |
Algeria | 11/102 (10.8) | BEB4 (4), BEB6 (2), BEB3 (1), I (1), J (1), PtEb XI (1), mixed (1) | [ 2 ] |
Argentina | 10/70 (14.3) | BEB4 (1); I (2), J (4); EbpC (1); BEB10 (1); D (1) | [ 5 ] |
Australia | 49/471 (10.4) | I (18), J (14), BEB4 (6), TAR_fc2 (6), TAR_fc1 (1), TAR_fc3 (1) | [ 48 ] |
Brazil | 79/452 (17.5) | I (35), BEB8 (23), BEB4 (7), BEB13 (7),BEB12 (5), D (4), BEB11 (3), EbpA (1), BEB14–BEB17 (1 each) | [ 4 ] |
China | 1817/10504 (17.3) | J (904); I (519); BEB4 (151), BEB6 (31), O (27), CM8 (18), COS-I (14), EbpC (14), CHN3 (14), D (13), CHN1 (11), CGC3 (11), CGC2 (8), CHC8 (7), CGC1 (6), CHN4 (6), CS-4 (6), Type IV (5), CM19 (5), BEB10 (3), CHG2 (2), CHG3 (2), CHN–DC1 (2), CHN–DC2 (2), CHN–DC3 (2), G (2), NECA1–NECA5, CHC1–CHC7, CHC9–CHC17, N , BEB8, CD6, H , CC4, CSX1–CSX2, CHN15, CM21, PN, and mixed (1 each) | [ 10 , 12 , 13 , 19 , 23 , 26 , 37 , ... |
…”